Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and peroxidized membrane lipids are reactive chemical entities that play dual roles as signaling molecules and mediators of cellular damage. ROS, such as superoxide and hydroxyl radicals, are generated during mitochondrial respiration and enzymatic reactions, while peroxidized lipids result from the oxidative attack on polyunsaturated fatty acids within cell membranes (Source: NIH PMC3914831). Excessive accumulation of these species leads to oxidative stress, causing irreversible damage to DNA, proteins, and lipid bilayers, which is a hallmark of diseases like Amyotrophic Lateral Sclerosis (ALS), atherosclerosis, and various cancers (Source: PubMed 22624696). Specifically, the accumulation of lipid hydroperoxides is the defining feature of ferroptosis, a non-apoptotic form of regulated cell death (Source: PubMed 28890325). Therapeutic intervention involves the use of radical scavengers and antioxidants, such as edaravone and N-acetylcysteine, which neutralize ROS or terminate the lipid peroxidation chain reaction (Source: PubChem CID 4021). Despite their clinical relevance, targeting these species is challenging because low levels of ROS are essential for normal physiological signaling, and broad-spectrum antioxidants can sometimes interfere with these vital processes (Source: PubMed 24591657).
Direct chemical neutralization of reactive oxygen species and the inhibition of the autoxidative chain reaction of membrane lipids to prevent cellular damage and ferroptotic cell death (Source: PubMed PMC4764129).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and peroxidized membrane lipids (ROS/LPO).